The Royal Devon and Exeter Hospital, is a large teaching hospital situated in Exeter, Devon, England. The hospital has two sites, situated in Wonford and Heavitree, Exeter, and is part of the Royal Devon and Exeter NHS Foundation Trust.

During the past decade, Royal Devon and Exeter Hospital (Wonford) conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 17 clinical trials were completed, i.e. on average, 60.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 14 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Devon and Exeter Hospital (Wonford)" #1 sponsor was "Hoffmann-La Roche" with 12 trials, followed by "Celgene" with 4 trials sponsored, "Takeda" with 3 trials sponsored, "Daiichi Sankyo, Inc." with 2 trials sponsored and "Millennium Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Devon and Exeter Hospital (Wonford)" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "European Network of Individualized Treatment in Endometrial Cancer - ENITEC" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Royal Devon and Exeter Hospital (Wonford)" are "Ulcerative Colitis" (5 trials), "Crohn Disease" (3 trials), "Crohn's Disease" (3 trials), "Breast Cancer" (2 trials) and "Colitis, Ulcerative" (2 trials). Many other conditions were trialed in "Royal Devon and Exeter Hospital (Wonford)" in a lesser frequency.

Most popular intervention types in "Royal Devon and Exeter Hospital (Wonford)" are "Drug" (27 trials), "Biological" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Etrolizumab" (4 trials), "Ocrelizumab" (3 trials), "Paclitaxel" (3 trials) and "GED-0301" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Devon and Exeter Hospital (Wonford)" are 28 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Devon and Exeter Hospital (Wonford)". undefined are not yet recruiting, 3 are recruiting, 10 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Royal Devon and Exeter Hospital (Wonford), undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Devon and Exeter Hospital (Wonford), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".